.png){kind=icon}
.png){kind=icon}
Return
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
.png){kind=icon}
OA
AI
Z
Y
Y
Y
X
J
X
C
X
丁
N
D
J
C
沈
DOI：10.1007/s40259-026-00793-x.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.9
Papers:
1.6K
Citations:
3.5K
Organization
Cited Papers